We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Mouse Model Shows Potential of Personalized Cancer Treatment Based on Live Cell Vaccination

By LabMedica International staff writers
Posted on 08 Sep 2015
Print article
Image: Cancerous melanoma cells, shown with their cell bodies (green) and nuclei (blue), are nestled in tiny hollow lumens within the polymeric cryogel (red) structure (Photo courtesy of the Wyss Institute at Harvard University).
Image: Cancerous melanoma cells, shown with their cell bodies (green) and nuclei (blue), are nestled in tiny hollow lumens within the polymeric cryogel (red) structure (Photo courtesy of the Wyss Institute at Harvard University).
A novel personalized approach to cancer immunotherapy is based on sponge-like "cryogels" that are loaded with a sampling of the patient's tumor cells together with immune system-stimulating reagents and then injected under the skin.

Cryogels are a type of hydrogel made up of cross-linked hydrophilic polymer chains that can hold up to 99% water. They are created by freezing a solution of the polymer during the gelling process. When thawed to room temperature, the substance turns into a highly interconnected pore-containing hydrogel, which is similar in composition to bodily soft tissues in terms of their water content, structure, and mechanics.

Investigators at Harvard University (Cambridge, MA, USA) worked with a mouse melanoma model. They injected some of these animals with sponge-like macroporous cryogels that had been loaded with GM-CSF (granulocyte macrophage colony-stimulating factor), serving as a DC (dendritic cell) enhancement factor. GM-CSF is a cytokine that functions as a white blood cell growth factor. GM-CSF stimulates stem cells to produce granulocytes (neutrophils, eosinophils, and basophils) and monocytes. Monocytes exit the circulation and migrate into tissue, whereupon they mature into macrophages and dendritic cells. Thus, it is part of the immune/inflammatory cascade, by which activation of a small number of macrophages can rapidly lead to an increase in their numbers, a process crucial for fighting infection.

In addition to GM-CSF, the cryogels were loaded with CpG ODN (CpG oligodeoxynucleotide, a molecule with immunostimulatory properties) that served as a DC activating factor and with a number of cancer cells harvested from the same mouse. These cryogels were injected subcutaneously into the mice to localize transplanted tumor cells and deliver immunomodulatory factors in a controlled spatiotemporal manner.

Results published in the August 12, 2015, online edition of the journal Nature Communications revealed that these vaccines elicited local infiltrates composed of conventional and plasmacytoid DCs, with the subsequent induction of potent, durable, and specific anti-tumor T-cell responses in the melanoma model. These responses induced tumors to shrink and even provided prophylactic protection from tumor growth. Cryogels could be delivered in a minimally invasive manner, bypassed the need for genetic modification of transplanted cancer cells and provided sustained release of immunomodulators.

"Instead of genetically engineering the cancer cells to influence the behavior of immune cells, we use immune-stimulating chemicals or biological molecules inserted alongside harvested cancer cells in the porous, sponge-like spaces of the cryogel vaccine," said senior author Dr. David Mooney, professor of bioengineering at Harvard University.

Related Links:

Harvard University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.